-
Something wrong with this record ?
Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia
T Stulc, M Vrablik, Z Kasalova, R Ceska, I Marinov
Language English Country Ireland
Document type Letter, Research Support, Non-U.S. Gov't
Grant support
NB5986
MZ0
CEP Register
NB7392
MZ0
CEP Register
NB6134
MZ0
CEP Register
Digital library NLK
Full text - Část
Full text - Část
Full text - Část
Source
Source
Source
NLK
ScienceDirect (archiv)
from 1993-01-01 to 2009-12-31
PubMed
12482568
Knihovny.cz E-resources
- MeSH
- Hypercholesterolemia * drug therapy physiopathology MeSH
- Clinical Trials as Topic MeSH
- Heptanoic Acids * pharmacology therapeutic use MeSH
- Cholesterol, LDL * drug effects MeSH
- Middle Aged MeSH
- Humans MeSH
- Cell Adhesion Molecules * physiology drug effects MeSH
- Pyrroles * pharmacology therapeutic use MeSH
- Hydroxymethylglutaryl-CoA Reductase Inhibitors * pharmacology therapeutic use MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
3rd Department of Internal Medicine 1st Faculty of Medicine Charles University prague Czech Republic
Institute of Hematology and Blood Transfusion Prague Czech Republic
obsahuje tabulku
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13010699
- 003
- CZ-PrNML
- 005
- 20130719134754.0
- 007
- ta
- 008
- 130321s2003 ie f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)12482568
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Štulc, Tomáš, $d 1965- $7 xx0056711 $u Third Department of Internal Medicine, First Faculty of Medicine, Charles University, prague, Czech Republic
- 245 10
- $a Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia / $c T Stulc, M Vrablik, Z Kasalova, R Ceska, I Marinov
- 500 __
- $a obsahuje tabulku
- 590 __
- $a bohemika - dle Pubmed
- 650 12
- $a molekuly buněčné adheze $x fyziologie $x účinky léků $7 D015815
- 650 12
- $a LDL-cholesterol $x účinky léků $7 D008078
- 650 02
- $a klinické zkoušky jako téma $7 D002986
- 650 02
- $a ženské pohlaví $7 D005260
- 650 12
- $a kyseliny heptylové $x farmakologie $x terapeutické užití $7 D006538
- 650 02
- $a lidé $7 D006801
- 650 12
- $a statiny $x farmakologie $x terapeutické užití $7 D019161
- 650 12
- $a hypercholesterolemie $x farmakoterapie $x patofyziologie $7 D006937
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a lidé středního věku $7 D008875
- 650 12
- $a pyrroly $x farmakologie $x terapeutické užití $7 D011758
- 655 _2
- $a dopisy $7 D016422
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vrablík, Michal, $d 1973- $7 xx0061419 $u Third Department of Internal Medicine, First Faculty of Medicine, Charles University, prague, Czech Republic
- 700 1_
- $a Kasalová, Zdislava $7 xx0115094 $u Third Department of Internal Medicine, First Faculty of Medicine, Charles University, prague, Czech Republic
- 700 1_
- $a Češka, Richard, $d 1957- $7 nlk19990074195 $u Third Department of Internal Medicine, First Faculty of Medicine, Charles University, prague, Czech Republic
- 700 1_
- $a Marinov, Iuri $7 xx0018261 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 773 0_
- $t Atherosclerosis $x 0021-9150 $g Roč. 166, č. 1 (2003), s. 197-198 $p Atherosclerosis $w MED00009284
- 773 0_
- $p Atherosclerosis $g 166(1):197-8, 2003 Jan $x 0021-9150
- 910 __
- $a ABA008 $b A 3574 $y 3 $z 0
- 990 __
- $a 20130321134301 $b ABA008
- 991 __
- $a 20130719135239 $b ABA008
- 999 __
- $a ok $b bmc $g 973648 $s 808966
- BAS __
- $a 3
- BMC __
- $a 2003 $b 166 $c 1 $d 197-198 $i 0021-9150 $m Atherosclerosis $x MED00009284 $n Atherosclerosis
- GRA __
- $a NB5986 $p MZ0
- GRA __
- $a NB7392 $p MZ0
- GRA __
- $a NB6134 $p MZ0
- LZP __
- $a NLK 2013-03/lpbo
